XML 44 R33.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation (Tables)
 12 Months Ended
Jan. 03, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Valuation Assumptions
The weighted-average assumpt
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the status of the Company’s non-vested restricted share units as of January 3, 2017 and changes during the year then ended is presented below:
 
 
Awards
 
Weighted-
Average
Grant Date Fair Value
Outstanding at December 29, 2015
 
—

 
$
—

Granted
 
201,135

 
10.38

Vested
 
(27,672
)
 
10.40

Forfeited
 
(50,698
)
 
8.68

Non-vested at January 3, 2017
 
122,765

 
$
10.20

A summary of the status of the Company’s non-vested options as of January 3, 2017 and changes during the year then ended is presented below:
 
 
Awards
 
Weighted-
Average
Grant Date Fair Value
Outstanding at December 29, 2015
 
1,122,266

 
$
5.80

Granted
 
117,000

 
2.85

Vested
 
(271,457
)
 
6.42

Forfeited
 
(393,654
)
 
5.58

Non-vested at January 3, 2017
 
574,155

 
$
8.58

:
 
 
Awards
 
Weighted-
Average
Exercise Price
 
Weighted-Average Remaining Contractual Term (1)
 
Aggregate
Intrinsic Value (2)
(in thousands)
Outstanding—December 31, 2013
 
3,309,872

 
$
10.59

 
 
 
 
Granted
 
269,552

 
30.40

 
 
 
 
Forfeited or expired
 
(73,673
)
 
19.72

 
 
 
 
Exercised
 
(260,487
)
 
8.85

 
 
 
 
Outstanding—December 30, 2014
 
3,245,264

 
$
12.17

 
 
 
 
Granted
 
921,825

 
14.55

 
 
 
 
Forfeited or expired
 
(307,318
)
 
18.76

 
 
 
 
Exercised
 
(792,363
)
 
8.86

 
 
 
 
Outstanding—December 29, 2015
 
3,067,408

 
$
13.08

 
 
 
 
Granted
 
117,000

 
8.34

 
 
 
 
Forfeited or expired
 
(505,182
)
 
16.55

 
 
 
 
Exercised
 
(104,294
)
 
9.13

 
 
 
 
Outstanding—January 3, 2017
 
2,574,932

 
$
12.34

 
3.86
 
$
—

Vested and expected to vest
 
2,530,517

 
$
12.29

 
3.77
 
$
—

Exercisable as of January 3, 2017
 
2,000,777

 
$
11.70

 
2.50
 
$
—

_____________
(1)
Weighted-average remaining contractual terms for options outstanding, vested and expected to vest and exercisable, as of January 3, 2017, include the options granted to Kevin Reddy which are outstanding, vested and exercisable and expire on October 23, 2017.
(2)
Aggregate intrinsic value represents the amount by which fair value of the Company’s stock exceeds the exercise price of the option as of January 3, 2017.